Cipla submits press release

22 Jul 2019 Evaluate

Cipla has informed about submission of press release dated 22nd July, 2019 regarding its wholly owned step down subsidiary lnvaGen Pharmaceuticals Inc. receives final approval for generic version of Pfizer's Lyrica (Pregabalin Capsules, 25mg, 50mg, 75mg, 100 mg, 150mg, 200mg, 225mg, 300mg). 

The above information is a part of company’s filings submitted to BSE.

Cipla Share Price

1324.40 4.05 (0.31%)
30-Jan-2026 14:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1603.00
Dr. Reddys Lab 1215.30
Cipla 1324.40
Zydus Lifesciences 884.35
Lupin 2144.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×